Skip to main content
TipRanks
Go Ultimate75% OFF

Pharmarise Holdings Corp. (2796) Ratios

0 Followers

Pharmarise Holdings Corp. Ratios

JP:2796's free cash flow for Q1 2026 was ¥0.00. For the 2026 fiscal year, JP:2796's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.

Financial ratios
RatiosMay 25May 24May 23May 22May 21
Liquidity Ratios
Current Ratio0.941.101.291.161.28
Quick Ratio0.740.761.040.921.01
Cash Ratio0.430.410.670.480.47
Solvency Ratio0.070.040.040.090.10
Operating Cash Flow Ratio0.230.110.250.260.08
Short-Term Operating Cash Flow Coverage0.690.501.020.720.31
Net Current Asset Value¥ -12.65B¥ -11.83B¥ -8.31B¥ -5.06B¥ -6.17B
Leverage Ratios
Debt-to-Assets Ratio0.460.450.430.390.42
Debt-to-Equity Ratio2.212.081.731.331.50
Debt-to-Capital Ratio0.690.680.630.570.60
Long-Term Debt-to-Capital Ratio0.590.620.570.430.52
Financial Leverage Ratio4.784.664.013.403.59
Debt Service Coverage Ratio0.390.460.330.460.78
Interest Coverage Ratio3.441.6613.8826.1523.38
Debt to Market Cap2.522.491.811.521.38
Interest Debt Per Share1347.601276.941217.69977.921069.19
Net Debt to EBITDA3.545.594.061.892.20
Profitability Margins
Gross Profit Margin12.42%12.92%15.51%15.63%15.73%
EBIT Margin1.41%0.29%0.38%2.12%2.69%
EBITDA Margin3.72%2.64%2.53%4.47%5.22%
Operating Profit Margin1.41%0.46%1.68%2.76%2.95%
Pretax Profit Margin1.00%0.01%0.26%2.02%2.56%
Net Profit Margin0.16%-0.58%-0.64%0.64%0.87%
Continuous Operations Profit Margin0.15%-0.60%-0.63%0.67%0.89%
Net Income Per EBT16.19%-4600.00%-245.45%31.74%33.81%
EBT Per EBIT71.22%2.71%15.61%72.95%86.97%
Return on Assets (ROA)0.35%-1.15%-1.19%1.42%1.88%
Return on Equity (ROE)1.65%-5.36%-4.77%4.84%6.77%
Return on Capital Employed (ROCE)5.25%1.47%4.87%10.58%9.95%
Return on Invested Capital (ROIC)0.64%-61.78%-10.13%2.76%2.97%
Return on Tangible Assets0.45%-1.49%-1.52%1.65%2.22%
Earnings Yield1.95%-6.70%-5.17%5.80%6.58%
Efficiency Ratios
Receivables Turnover18.5616.7715.3212.9312.09
Payables Turnover9.198.328.0910.3210.58
Inventory Turnover21.6513.3417.4019.1718.89
Fixed Asset Turnover9.128.818.798.668.12
Asset Turnover2.131.991.852.222.17
Working Capital Turnover Ratio343.2729.5423.7526.4229.03
Cash Conversion Cycle-3.215.26-0.3211.9115.03
Days of Sales Outstanding19.6621.7723.8328.2230.20
Days of Inventory Outstanding16.8627.3620.9819.0419.32
Days of Payables Outstanding39.7343.8745.1335.3634.48
Operating Cycle36.5249.1344.8147.2649.52
Cash Flow Ratios
Operating Cash Flow Per Share286.16115.80257.89268.0776.41
Free Cash Flow Per Share225.4059.53199.07210.4126.47
Dividend Paid and CapEx Coverage Ratio3.841.523.643.741.19
Capital Expenditure Coverage Ratio4.712.064.384.651.53
Operating Cash Flow Coverage Ratio0.220.090.210.280.07
Operating Cash Flow to Sales Ratio0.050.020.050.050.01
Free Cash Flow Yield44.63%12.27%30.86%34.44%3.64%
Valuation Ratios
Price-to-Earnings (P/E) Ratio50.75-14.96-19.3417.2515.20
Price-to-Sales (P/S) Ratio0.080.090.120.110.13
Price-to-Book (P/B) Ratio0.850.800.920.831.03
Price-to-Free Cash Flow (P/FCF) Ratio2.248.153.242.9027.50
Price-to-Operating Cash Flow Ratio1.764.192.502.289.53
Price-to-Earnings Growth (PEG) Ratio-0.395.360.10-0.663.28
Enterprise Value Multiple5.778.868.984.364.72
Enterprise Value14.92B14.88B12.39B10.14B12.71B
EV to EBITDA5.778.868.984.364.72
EV to Sales0.210.230.230.190.25
EV to Free Cash Flow5.7822.085.915.1351.47
EV to Operating Cash Flow4.5511.354.564.0217.83
Tangible Book Value Per Share-64.51-30.5697.02397.53329.00
Shareholders’ Equity Per Share597.28606.72699.35731.98708.04
Tax and Other Ratios
Effective Tax Rate0.8548.753.390.670.65
Revenue Per Share6068.175609.475175.405534.765530.61
Net Income Per Share9.86-32.50-33.3535.4247.90
Tax Burden0.16-46.00-2.450.320.34
Interest Burden0.710.040.680.950.95
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.110.080.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality29.01-3.56-7.732.400.54

Currency in JPY